Oleandomycin
From Wikipedia, the free encyclopedia
Oleandomycin
|
|
Systematic (IUPAC) name | |
(3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-14-((2S,3R,4S,6R)-4-(dimethylamino) -3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6-hydroxy-12-((2R,4S,5S,6S) -5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yloxy)-5,7,8,11,13,15 -hexamethyl-1,9-dioxaspiro[2.13]hexadecane-4,10-dione |
|
Identifiers | |
CAS number | |
ATC code | J01 |
PubChem | |
Chemical data | |
Formula | C35H61NO12 |
Mol. mass | 687.858 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Oleandomycin is a macrolide antibiotic.
|